5-HT receptors and KV channel internalization

Advances in Experimental Medicine and Biology

Volumn 661, Issue , 2010, Pages 391-401

  Cogolludo, Angel ^a   Perez Vizcaino, Francisco ^a  

^a SCHOOL OF MEDICINE   (Spain)

Author keywords

Caveola; Endocytosis; Potassium channels; Pulmonary arteries; Serotonin

Indexed keywords

2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; AMINOREX; CAVEOLIN 1; CONCANAVALIN A; ENDOTHELIN 1; FENFLURAMINE; PHOSPHOLIPASE C; POTASSIUM CHANNEL KV; SEROTONIN; SEROTONIN 2A RECEPTOR; SEROTONIN RECEPTOR; UNCLASSIFIED DRUG; VOLTAGE GATED POTASSIUM CHANNEL; ISOPROTEIN; VASOCONSTRICTOR AGENT;

ARTERY MUSCLE; ARTERY TONE; CAVEOLA; CELL COMPARTMENTALIZATION; CELL MEMBRANE POTENTIAL; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CHANNEL GATING; CONFERENCE PAPER; DRUG MECHANISM; DRUG TARGETING; ENDOCYTOSIS; ENZYME ACTIVATION; HUMAN; HYPOXIA; INTERNALIZATION; INTRACELLULAR SIGNALING; LUNG CIRCULATION; LUNG VASOCONSTRICTION; MOLECULAR INTERACTION; NONHUMAN; PATHOGENESIS; POTASSIUM CURRENT; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PULMONARY ARTERY; PULMONARY HYPERTENSION; RISK FACTOR; ANIMAL; DRUG EFFECT; GENETICS; LUNG; METABOLISM; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION; VASCULARIZATION; VASOCONSTRICTION;

ANIMALS; ENDOCYTOSIS; HUMANS; LUNG; POTASSIUM CHANNELS, VOLTAGE-GATED; PROTEIN ISOFORMS; PULMONARY CIRCULATION; RECEPTORS, SEROTONIN; SEROTONIN; SIGNAL TRANSDUCTION; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 77951238137     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-60761-500-2_25     Document Type: Conference Paper

References (50)

1. Humbert M, Morrell NW, Archer SL et al (2004) Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol 43:13S-24S (Pubitemid 38759713)
2. Yuan JX-J, Rubin LJ (2005) Pathogenesis of pulmonary arterial hypertension. Circulation 111:534-538
3. Long L, MacLean MR, Jeffery TK et al (2006) Serotonin increases susceptibility to pulmonary hypertension in BMPR2-deficient mice. Circ Res 98:818-827
4. Fantozzi I, Platoshyn O, Wong AH et al (2006) Bone morphogenetic protein-2 upregulates expression and function of voltage-gated K+ channels in human pulmonary artery smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 291:L993-L1004 (Pubitemid 44772062)
5. Atanassoff PG Weiss BM Schmid ER Tornic M (1992) Pulmonary hypertension and dexfenfluramine Lancet 339:436
6. Dempsie Y, MacLean MR (2008) Pulmonary hypertension: therapeutic targets within the serotonin system. Br J Pharmacol 155:455-462
7. Launay JM, Hervé P, Peoch K et al (2002) Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension. Nat Med 8:1129-1135 (Pubitemid 35175968)
8. Hervé P, Launay JM, Scrobohaci ML et al (1995) Increased plasma serotonin in primary pulmonary hypertension. Am J Med 99:249-254
9. Eddahibi S, Humbert M, Fadel E et al. (2001) Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension. J Clin Invest 108:1141-1150 (Pubitemid 32995372)
10. Sullivan CC, Du L, Chu D et al (2003) Induction of pulmonary hypertension by an angiopoietin 1/TIE2/serotonin pathway. Proc Natl Acad Sci U S A 100:12331-12336 (Pubitemid 37271560)
11. Eddahibi S, Hanoun N, Lanfumey L et al (2000) Attenuated hypoxic pulmonary hypertension in mice lacking the 5-hydroxytryptamine transporter gene. J Clin Invest 105:1555-1562 (Pubitemid 30390306)
12. Keegan A, Morecroft I, Smillie D, Hicks MN, MacLean MR (2001) Contribution of the 5-HT1B receptor to hypoxia-induced pulmonary hypertension: converging evidence using 5-HT1B-receptor knockout mice and the 5-HT1B/1D-receptor antagonist GR127935. Circ Res 89:1231-1239 (Pubitemid 34627883)
13. Guignabert C, Raffestin B, Benferhat R et al (2005) Serotonin transporter inhibition prevents and reverses monocrotaline-induced pulmonary hypertension in rats. Circulation 111:2812-2819 (Pubitemid 40791554)
14. Hironaka E, Hongo M, Sakai A et al (2003) Serotonin receptor antagonist inhibits monocrotaline-induced pulmonary hypertension and prolongs survival in rats. Cardiovasc Res 60:692-699 (Pubitemid 37501127)
15. Yuan X-J (1995) Voltage-gated K+ currents regulate resting membrane potential and [Ca2+]i in pulmonary arterial myocytes. Circ Res 77:370-378
16. Archer S, Souil E, Dinh-Xuan AT et al (1998) Molecular identification of the role of voltagegated K+ channels, Kv1.5 and Kv1.2, in hypoxic pulmonary vasoconstriction and control of resting membrane potential in rat pulmonary artery myocytes. J Clin Invest 101:2319-2330 (Pubitemid 28270426)
17. Burg ED, Remillard CV, Yuan JX-J (2008) Potassium channels in the regulation of pulmonary artery smooth muscle cell proliferation and apoptosis: pharmacotherapeutic implications. Br J Pharmacol 153(Suppl 1):S99-S111 (Pubitemid 351341007)
18. Gurney AM, Osipenko ON, MacMillan D, McFarlane KM, Tate RJ, Kempsill FE (2003) Twopore domain K channel, TASK-1, in pulmonary artery smooth muscle cells. Circ Res 93:957-964 (Pubitemid 37433233)
19. Platoshyn O, Remillard CV, Fantozzi I et al (2004) Diversity of voltage-dependent K+ channels in human pulmonary artery smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 287:L226-L238 (Pubitemid 38787670)
20. Coppock EA, Martens JR, Tamkun MM (2001) Molecular basis of hypoxia-induced pulmonary vasoconstriction: role of voltage-gated K+ channels. Am J Physiol Lung Cell Mol Physiol 281:L1-L12
21. McMurtry MS, Bonnet S, Wu X et al (2004) Dichloroacetate prevents and reverses pulmonary hypertension by inducing pulmonary artery smooth muscle cell apoptosis. Circ Res 95:830-840 (Pubitemid 39390586)
22. Yuan X-J Wang J Juhaszova M Gaine SP Rubin L (1998) Attenuated K+ channel gene transcription in primary pulmonary hypertension. Lancet 351:726-727 (Pubitemid 28105348)
23. Pozeg ZI, Michelakis ED, McMurtry MS et al (2003) In vivo gene transfer of the O2-sensitive potassium channel Kv1.5 reduces pulmonary hypertension and restores hypoxic pulmonary vasoconstriction in chronically hypoxic rats. Circulation 107:2037-2044 (Pubitemid 36506080)
24. McMurtry MS, Archer SL, Altieri DC et al (2005) Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension. J Clin Invest 115:1479-1491 (Pubitemid 40814657)
25. Archer SL, Huang J, Henry T, Peterson D, Weir EK (1993) A redox-based O2 sensor in rat pulmonary vasculature. Circ Res 73:1100-1112 (Pubitemid 23340205)
26. Shimoda LA, Sylvester JT, Sham JSK (1998) Inhibition of voltage-gated K+ current in intrapulmonary arterial myocytes by endothelin-1. Am J Physiol 274:L842-L843
27. Cogolludo A, Moreno L, Boscá L, Tamargo J, Pérez-Vizcaino F (2003) Thromboxane A2- induced inhibition of voltage-gated K+ channels and pulmonary vasoconstriction. Role of protein kinase Cz. Circ Res 93:656-663 (Pubitemid 37222162)
28. Cogolludo A, Moreno L, Lodi F, Tamargo J, Perez-Vizcaino F (2005) Postnatal maturational shift from PKCz and voltage-gated K+ channels to RhoA/Rho kinase in pulmonary vasoconstriction. Cardiovasc Res 66:84-93 (Pubitemid 40357871)
29. Cogolludo A, Moreno L, Lodi F et al (2006) Serotonin inhibits voltage-gated K+ currents in pulmonary artery smooth muscle cells: role of 5-HT2A receptors, caveolin-1, and Kv1.5 channel internalization. Circ Res 98:931-938
30. Wang J, Juhaszova M, Conte JV, Gaine SP, Rubin LJ, Yuan JX-J (1998) Action of fenfluramine on voltage-gated K+ channels in human pulmonary artery smooth-muscle cells. Lancet 352:290 (Pubitemid 28340155)
31. Hong Z, Smith AJ, Archer SL et al (2005) Pergolide is an inhibitor of voltage-gated potassium channels, including Kv1.5, and causes pulmonary vasoconstriction. Circulation 112:1494-1499 (Pubitemid 41291775)
32. Michelakis ED, Thébaud B, Weir EK, Archer SL (2004) Hypoxic pulmonary vasoconstriction: redox regulation of O2-sensitive K+ channels by a mitochondrial O2-sensor in resistance artery smooth muscle cells. J Mol Cell Cardiol 37:1119-1136 (Pubitemid 39575159)
33. Cogolludo A, Frazziano G, Cobeño L et al (2006) Role of reactive oxygen species in Kv channel inhibition and vasoconstriction induced by TP receptor activation in rat pulmonary arteries. Ann N Y Acad Sci 1091:41-51 (Pubitemid 47092223)
34. Moreno L, Frazziano G, Cogolludo A, Cobeño L, Tamargo J, Perez-Vizcaino F (2007) Role of protein kinase Czeta and its adaptor protein p62 in voltage-gated potassium channel modulation in pulmonary arteries. Mol Pharmacol 72:1301-1309 (Pubitemid 350012603)
35. Talley EM, Lei Q, Sirois JE, Bayliss DA (2000) TASK-1, a two-pore domain K+ channel, is modulated by multiple neurotransmitters in motoneurons. Neuron 25:399-410
36. Tamir H, Hsiung SC, Yu PY et al (1992) Serotonergic signalling between thyroid cells: protein kinase C and 5-HT2 receptors in the secretion and action of serotonin. Synapse 12:155-168
37. Moscat J, Diaz-Meco MT (2000) The atypical protein kinase Cs. Functional specificity mediated by specific protein adapters. EMBO Rep 1:399-403
38. Gong J, Xu J, Bezanilla M, van Huizen R, Derin R, Li M (1999) Differential stimulation of PKC phosphorylation of potassium channels by ZIP1 and ZIP2. Science 285:1565-1569 (Pubitemid 29420580)
39. Kim Y, Uhm DY, Shin J, Chung S (2004) Modulation of delayed rectifier potassium channel by protein kinase C zeta-containing signaling complex in pheochromocytoma cells. Neuroscience 125:359-368 (Pubitemid 38446742)
40. Shaul PW, Anderson RG (1998) Role of plasmalemmal caveolae in signal transduction. Am J Physiol 275:L843-L851
41. Martens JR, Sakamoto N, Sullivan SA, Grobaski TD, Tamkun MM (2001) Isoform-specific localization of voltage-gated K+ channels to distinct lipid raft populations. Targeting of Kv1.5 to caveolae. J Biol Chem 276:8409-8414
42. McEwen DP, Li Q, Jackson S, Jenkins PM, Martens JR (2008) Caveolin regulates Kv1.5 trafficking to cholesterol-rich membrane microdomains. Mol Pharmacol 73:678-685 (Pubitemid 351397873)
43. Martínez-Mármol R, Villalonga N, Solé L et al (2008) Multiple Kv1.5 targeting to membrane surface microdomains. Cell Physiol 217:667-673
44. Allen JA, Yadav PN, Roth BL (2008) Insights into the regulation of 5-HT2A serotonin receptors by scaffolding proteins and kinases. Neuropharmacology 55:961-968
45. Zhao YY, Liu Y, Stan RV et al (2002) Defects in caveolin-1 cause dilated cardiomyopathy and pulmonary hypertension in knockout mice. Proc Natl Acad Sci U S A 99:11375-11380 (Pubitemid 34920933)
46. Huang J, Kaminski PM, Edwards JG et al (2008) Pyrrolidine dithiocarbamate restores endothelial cell membrane integrity and attenuates monocrotaline-induced pulmonary artery hypertension. Am J Physiol Lung Cell Mol Physiol 294:L1250-L1259
47. Achcar RO, Demura Y, Rai PR et al (2006) Loss of caveolin and heme oxygenase expression in severe pulmonary hypertension. Chest 129:696-705
48. Patel HH, Zhang S, Murray F et al (2007) Increased smooth muscle cell expression of caveolin-1 and caveolae contribute to the pathophysiology of idiopathic pulmonary arterial hypertension. FASEB J 21:2970-2979 (Pubitemid 47372763)
49. Ishiguro M, Morielli AD, Zvarova K, Tranmer BI, Penar PL, Wellman GC (2006) Oxyhemoglobin-induced suppression of voltage-dependent K+ channels in cerebral arteries by enhanced tyrosine kinase activity. Circ Res 99:1252-1260 (Pubitemid 44808662)
50. B hattacharya S, Puri S, Miledi R, Panicker MM (2002) Internalization and recycling of 5-HT2A receptors activated by serotonin and protein kinase C-mediated mechanisms. Proc Natl Acad Sci U S A 99:14470-14475